The Wockhardt Group, once a prominent player in the pharmaceutical industry, is facing financial difficulties. With mounting debts and a struggling business, the group's significant assets are now scheduled for auction. This unexpected development has sent shockwaves through the industry, leaving many observers. It remains to be seen who will ulti